Payment Commission Data Act of 2019

Bill: 116-hr-1781
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
Introduced: 2019-03-14 in the House
Policy area: Health
Subjects: Advisory bodies
Health care costs and insurance
Health information and medical records
Health programs administration and funding
Medicaid
Medicare
Prescription drugs

Summary:
action_date: 2019-03-14
text: 

Payment Commission Data Act of 2019

 
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

action_date: 2019-10-28
text: 

Payment Commission Data Act of 2019

 
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.


Legislative actions:
action_date: 2019-10-29
text: Received in the Senate and Read twice and referred to the Committee on Finance.
action_date: 2019-10-28
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2019-10-28
text: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H8526)
action_date: 2019-10-28
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H8526)
action_date: 2019-10-28
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 1781.
action_date: 2019-10-28
text: Considered under suspension of the rules. (consideration: CR H8526-8527)
action_date: 2019-10-28
text: Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
action_date: 2019-10-28
text: Placed on the Union Calendar, Calendar No. 205.
action_date: 2019-10-28
text: Committee on Ways and Means discharged.
action_date: 2019-10-28
text: Committee on Ways and Means discharged.
action_date: 2019-10-28
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
action_date: 2019-10-28
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
action_date: 2019-04-03
text: Ordered to be Reported (Amended) by Voice Vote.
action_date: 2019-04-03
text: Committee Consideration and Mark-up Session Held.
action_date: 2019-03-27
text: Forwarded by Subcommittee to Full Committee by Voice Vote .
action_date: 2019-03-27
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2019-03-15
text: Referred to the Subcommittee on Health.
action_date: 2019-03-14
text: Referred to the Subcommittee on Health.
action_date: 2019-03-14
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2019-03-14
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2019-03-14
text: Introduced in House
action_date: 2019-03-14
text: Introduced in House